
Alafair Biosciences received two FDA 510(k) clearances for VersaCoat Tendon Protector and VersaCoat Nerve Protector, marketed as a single product, VersaCoat Flowable Hydrogel. VersaCoat is a syringe-deliverable gel that provides a protective, gliding surface designed to limit post-operative tethering in surgical procedures involving tendons, ligaments, skeletal muscles and peripheral nerves (including nerve roots) in patients of all ages.
VersaCoat Flowable Hydrogel uses the same proprietary, collagen-free hyaluronic acid and alginate formulation with VersaWrap Hydrogel Sheet (VersaWrap Tendon Protector, VersaWrap Nerve Protector). Both components fully bioresorb without leaving residual material, allowing tissue to return to its pre-injury state.
“VersaWrap Hydrogel Sheet has generated meaningful adoption with more than 30,000 implants and consistent acceptance from surgeons and GPOs,” stated John Joyoprayitno, President & CEO of Alafair Biosciences. “By delivering our proven hyaluronic acid and alginate formulation in a flowable format, VersaCoat Flowable Hydrogel responds to surgeon feedback for larger volumes and delivery to hard‑to‑reach tissues, including minimally invasive approaches. This added versatility supports expanded use in a variety of specialties including extremities, sports medicine, and trauma.”
Source: Alafair Biosciences, Inc.
Alafair Biosciences received two FDA 510(k) clearances for VersaCoat Tendon Protector and VersaCoat Nerve Protector, marketed as a single product, VersaCoat Flowable Hydrogel. VersaCoat is a syringe-deliverable gel that provides a protective, gliding surface designed to limit post-operative tethering in surgical procedures involving tendons,...
Alafair Biosciences received two FDA 510(k) clearances for VersaCoat Tendon Protector and VersaCoat Nerve Protector, marketed as a single product, VersaCoat Flowable Hydrogel. VersaCoat is a syringe-deliverable gel that provides a protective, gliding surface designed to limit post-operative tethering in surgical procedures involving tendons, ligaments, skeletal muscles and peripheral nerves (including nerve roots) in patients of all ages.
VersaCoat Flowable Hydrogel uses the same proprietary, collagen-free hyaluronic acid and alginate formulation with VersaWrap Hydrogel Sheet (VersaWrap Tendon Protector, VersaWrap Nerve Protector). Both components fully bioresorb without leaving residual material, allowing tissue to return to its pre-injury state.
“VersaWrap Hydrogel Sheet has generated meaningful adoption with more than 30,000 implants and consistent acceptance from surgeons and GPOs,” stated John Joyoprayitno, President & CEO of Alafair Biosciences. “By delivering our proven hyaluronic acid and alginate formulation in a flowable format, VersaCoat Flowable Hydrogel responds to surgeon feedback for larger volumes and delivery to hard‑to‑reach tissues, including minimally invasive approaches. This added versatility supports expanded use in a variety of specialties including extremities, sports medicine, and trauma.”
Source: Alafair Biosciences, Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.